Compass Biotechnologies, Inc. Stock Other OTC
Equities
US20452Q1031
Pharmaceuticals
Sales 2018 | - | Sales 2019 | - | Capitalization | 158K 215K |
---|---|---|---|---|---|
Net income 2018 | - 0 | Net income 2019 | - 0 | EV / Sales 2018 | - |
Net Debt 2018 | 516K 704K | Net Debt 2019 | 480K 656K | EV / Sales 2019 | - |
P/E ratio 2018 |
-2.59
x | P/E ratio 2019 |
-3.95
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 20-04-17 |
Mathew Knowles
SAM | Sales & Marketing | - | 19-07-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 20-04-17 |
1st Jan change | Capi. | |
---|---|---|
+44.36% | 6.29B | |
-13.52% | 4.55B | |
+10.85% | 3.27B | |
-6.52% | 3.23B | |
-0.71% | 2.56B | |
+51.14% | 2B | |
-5.22% | 1.68B | |
+1.29% | 1.64B | |
+57.69% | 1.6B |